SECIS-binding protein 2 promotes cell survival by protecting against oxidative stress

Antioxidants and Redox Signaling

Volumn 12, Issue 7, 2010, Pages 797-808

  Papp, Laura V ^a   Lu, Jun ^b   Bolderson, Emma ^a   Boucher, Didier ^a   Singh, Ravindra ^c   Holmgren, Arne ^b   Khanna, Kum Kum ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b KAROLINSKA INSTITUTE   (Sweden)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTISENSE OLIGONUCLEOTIDE; BINDING PROTEIN; CASPASE; CYTOCHROME C; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; SECIS BINDING PROTEIN 2; SELENOPROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CELL GRANULE; CELL PROTECTION; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVE SITE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FAMILY;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CASPASES; CELL CYCLE; CELL LINE; CELL SURVIVAL; DNA DAMAGE; HUMANS; LIPID PEROXIDATION; OLIGONUCLEOTIDES, ANTISENSE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA-BINDING PROTEINS; SELENOCYSTEINE; SELENOPROTEINS;

EID: 77649253577     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2913     Document Type: Article

References (48)

1. Altieri F, Grillo C, Maceroni M, and Chichiarelli S. DNA damage and repair: from molecular mechanisms to health implications. Antioxid Redox Signal 10: 891-937, 2008.
2. Anderson P and Kedersha N. Stressful initiations. J Cell Sci 115: 3227-3234, 2002.
3. Anestal K and Arner ES. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. J Biol Chem 278: 15966-15972, 2003.
4. Arner ES and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267: 6102-6109, 2000.
5. Bakkenist CJ and Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506, 2003.
6. Ben Jilani KE, Panee J, He Q, Berry MJ, and Li PA. Over-expression of selenoprotein H reduces Ht22 neuronal cell death after UVB irradiation by preventing superoxide formation. Int J Biol Sci 3: 198-204, 2007.
7. Benz CC and Yau C. Ageing, oxidative stress and cancer: paradigms in parallax. Nat Rev Cancer 8: 875-879, 2008.
8. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, Harney JW, and Larsen PR. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3' untranslated region. Nature 353: 273-276, 1991.
9. Berry MJ, Banu L, Harney JW, and Larsen PR. Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J 12: 3315-3322, 1993.
10. Bosl MR, Takaku K, Oshima M, Nishimura S, Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc Natl Acad Sci USA 94: 5531-5534, 1997.
11. Chavatte L, Brown BA, and Driscoll DM. Ribosomal protein L30 is a component of the UGA-selenocysteine recoding machinery in eukaryotes. Nat Struct Mol Biol 12: 408-416, 2005.
12. Chen HT, Bhandoola A, Difilippantonio MJ, Zhu J, Brown MJ, Tai X, Rogakou EP, Brotz TM, Bonner WM, Ried T, and Nussenzweig A. Response to RAG-mediated VDJ cleavage by NBS1 and gamma-H2AX. Science 290: 1962-1965, 2000.
13. Copeland PR and Driscoll DM. Purification, redox sensitivity, and RNA binding properties of SECIS-binding protein 2: a protein involved in selenoprotein biosynthesis. J Biol Chem 274: 25447-25454, 1999.
14. Copeland PR, Fletcher JE, Carlson BA, Hatfield DL, and Driscoll DM. A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J 19: 306-314, 2000.
15. Copeland PR, Stepanik VA, and Driscoll DM. Insight into mammalian selenocysteine insertion: domain structure and ribosome binding properties of Sec insertion sequence binding protein 2. Mol Cell Biol 21: 1491-1498, 2001.
16. Cox AG, Brown KK, Arner ES, and Hampton MB. The thioredoxin reductase inhibitor auranofin triggers apopto-sis through a Bax=Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochem Pharmacol 76: 1097-1109, 2008.
17. Czerski L and Nunez G. Apoptosome formation and caspase activation: is it different in the heart? J Mol Cell Cardiol 37: 643-652, 2004.
18. Di Cosmo C, McLellan N, Liao XH, Khanna KK, Weiss RE, Papp L, and Refetoff S. Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X). J Clin Endocrinol Metab 94: 4003-4009, 2009.
19. Dumitrescu AM, Liao XH, Abdullah MS, Lado-Abeal J, Majed FA, Moeller LC, Boran G, Schomburg L, Weiss RE, and Refetoff S. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 37: 1247-1252, 2005.
20. Fagegaltier D, Hubert N, Yamada K, Mizutani T, Carbon P, and Krol A. Characterization of mSelB, a novel mammalian elongation factor for selenoprotein translation. EMBO J 19: 4796-4805, 2000.
21. Goodman JM. The gregarious lipid droplet. J Biol Chem 283: 28005-28009, 2008.
22. Khanna KK, Beamish H, Yan J, Hobson K, Williams R, Dunn I, and Lavin MF. Nature of G1=S cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene 11: 609-618, 1995.
23. Khanna KK, Lavin MF, Jackson SP, and Mulhern TD. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ 8: 1052-1065, 2001.
24. Khatchadourian A and Maysinger D. Lipid droplets: their role in nanoparticle-induced oxidative stress. Mol Pharm 6: 1125-1137, 2009.
25. Kim KH, Gao Y, Walder K, Collier GR, Skelton J, and Kis-sebah AH. SEPS1 protects RAW264.7 cells from pharmacological ER stress agent-induced apoptosis. Biochem Biophys Res Commun 354: 127-132, 2007.
26. Kluck RM, Bossy-Wetzel E, Green DR, and Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
27. Kroemer G, Dallaporta B, and Resche-Rigon M. The mito-chondrial death=life regulator in apoptosis and necrosis. Annu Rev Physiol 60: 619-642, 1998.
28. Lee BJ, Worland PJ, Davis JN, Stadtman TC, and Hatfield DL. Identification of a selenocystenyl-tRNA(Ser) in mammalian cells that recognizes the nonsense codon, UGA. J Biol Chem 264: 9724-9727, 1989.
29. Lennon SV, Martin SJ, and Cotter TG. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 24: 203-214, 1991.
30. Low SC, Grundner-Culemann E, Harney JW, and Berry MJ. SECIS-SBP2 interactions dictate selenocysteine incorporation efficiency and selenoprotein hierarchy. EMBO J 19: 6882-6890, 2000.
31. Lu J and Holmgren A. Selenoproteins. J Biol Chem 284: 723-727, 2009.
32. Papp LV, Lu J, Holmgren A, and Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 9: 775-806, 2007.
33. Papp LV, Lu J, Striebel F, Kennedy D, Holmgren A, and Khanna KK. The redox state of SECIS binding protein 2 controls its localization and selenocysteine incorporation function. Mol Cell Biol 26: 4895-4910, 2006.
34. Papp LV, Wang J, Kennedy D, Boucher D, Zhang Y, Gladyshev VN, Singh RN, and Khanna KK. Functional characterization of alternatively spliced human SECISBP2 transcript variants. Nucleic Acids Res 36: 7192-7206, 2008.
35. Petersen S, Casellas R, Reina-San-Martin B, Chen HT, Difi-lippantonio MJ, Wilson PC, Hanitsch L, Celeste A, Mur-amatsu M, Pilch DR, Redon C, Ried T, Bonner WM, Honjo T, Nussenzweig MC, and Nussenzweig A. AID is required to initiate Nbs1=gamma-H2AX focus formation and mutations at sites of class switching. Nature 414: 660-665, 2001.
36. Potashkin JA and Meredith GE. The role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease. Antioxid Redox Signal 8: 144-151, 2006.
37. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, and Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858-5868, 1998.
38. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, and Choi AM. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 9: 49-89, 2007.
39. Sahu NK, Shilakari G, Nayak A, and Kohli DV. Antisense technology: a selective tool for gene expression regulation and gene targeting. Curr Pharm Biotechnol 8: 291-304, 2007.
40. Saito Y, Yoshida Y, Akazawa T, Takahashi K, and Niki E. Cell death caused by selenium deficiency and protective effect of antioxidants. J Biol Chem 278: 39428-39434, 2003.
41. Sedelies KA, Ciccone A, Clarke CJ, Oliaro J, Sutton VR, Scott FL, Silke J, Susanto O, Green DR, Johnstone RW, Bird PI, Trapani JA, and Waterhouse NJ. Blocking granule-mediated death by primary human NK cells requires both protection of mitochondria and inhibition of caspase activity. Cell Death Differ 15: 708-717, 2008.
42. Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Radmark O, Wurst W, Born-kamm GW, Schweizer U, and Conrad M. Glutathione per-oxidase 4 senses and translates oxidative stress into 12=15-lipoxygenase dependent-and AIF-mediated cell death. Cell Metab 8: 237-248, 2008.
43. Squires JE, Davy P, Berry MJ, and Allsopp R. Attenuated expression of SECIS binding protein 2 causes loss of telo-meric reserve without affecting telomerase. Exp Gerontol 44: 619-623, 2009.
44. Suraweera A, Becherel OJ, Chen P, Rundle N, Woods R, Nakamura J, Gatei M, Criscuolo C, Filla A, Chessa L, Fusser M, Epe B, Gueven N, and Lavin MF. Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage. J Cell Biol 177: 969-979, 2007.
45. Suzuki T, Kelly VP, Motohashi H, Nakajima O, Takahashi S, Nishimura S, and Yamamoto M. Deletion of the selenocys-teine tRNA gene in macrophages and liver results in compensatory gene induction of cytoprotective enzymes by Nrf2. J Biol Chem 283: 2021-2030, 2008.
46. Tujebajeva RM, Copeland PR, Xu XM, Carlson BA, Harney JW, Driscoll DM, Hatfield DL, and Berry MJ. Decoding apparatus for eukaryotic selenocysteine insertion. EMBO Rep 1: 158-163, 2000.
47. Xu XM, Carlson BA, Mix H, Zhang Y, Saira K, Glass RS, Berry MJ, Gladyshev VN, and Hatfield DL. Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol 5: e4, 2007.
48. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, and Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.